Bristol-Myers Squibb [clinicaltrials_resource:d3a813b7ce44062a0bf05c46ffe9add7]
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine [clinicaltrials:NCT00002035]Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002240]A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers [clinicaltrials:NCT00002261]A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine [clinicaltrials:NCT00002274]A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine [clinicaltrials:NCT00002280]Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen [clinicaltrials:NCT00002429]A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors [clinicaltrials:NCT00030173]clinicaltrials:NCT00035932Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma [clinicaltrials:NCT00050102]Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer [clinicaltrials:NCT00050596]A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors [clinicaltrials:NCT00057473]clinicaltrials:NCT00065507A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy [clinicaltrials:NCT00067782]Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) [clinicaltrials:NCT00080262]clinicaltrials:NCT00080301Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode [clinicaltrials:NCT00080314]Study of Aripiprazole in Subjects With Alcoholism [clinicaltrials:NCT00082199]clinicaltrials:NCT00082433Study of MDX-010 in Stage IV Breast Cancer [clinicaltrials:NCT00083278]Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients [clinicaltrials:NCT00084253]clinicaltrials:NCT00084656A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode [clinicaltrials:NCT00094432]clinicaltrials:NCT00094653clinicaltrials:NCT00095147BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [clinicaltrials:NCT00095173]clinicaltrials:NCT00095238Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension [clinicaltrials:NCT00095394]Aripiprazole in Patients With Acute Mania [clinicaltrials:NCT00095511]Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder [clinicaltrials:NCT00095524]Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension [clinicaltrials:NCT00095550]Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia [clinicaltrials:NCT00095719]A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder [clinicaltrials:NCT00095745]A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [clinicaltrials:NCT00095758]A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [clinicaltrials:NCT00095823]clinicaltrials:NCT00096785Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program [clinicaltrials:NCT00096811]clinicaltrials:NCT00097266Phase I (PH I) Mad Refractory Solid Tumor Study [clinicaltrials:NCT00099606]Aripiprazole Oral Acceptability Trial [clinicaltrials:NCT00101569]clinicaltrials:NCT00101595
overall official [clinicaltrials_vocabulary:overall-official]
Bristol-Myers Squibb [clinicaltrials_resource:d3a813b7ce44062a0bf05c46ffe9add7]
Bio2RDF identifier
d3a813b7ce44062a0bf05c46ffe9add7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d3a813b7ce44062a0bf05c46ffe9add7
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
Clinical.Trials@BMS.com
Clinical.Trials@bms.com
ClinicalTrialTransparency@astrazeneca.com
ClinicalTrials@bms.com
Michelle.Grossman@parexel.com
bauera@medicine.ufl.edu
clinical.trials@bms.com
last name [clinicaltrials_vocabulary:last-name]
Bristol-Myers Squibb
phone [clinicaltrials_vocabulary:phone]
+49401818863216
203-737-1889
205-638-2792
205-934-7220
205-934-7630
205-949-1907
205-975-8091
205-996-9191
205-996-9569
251-607-5283
phone ext [clinicaltrials_vocabulary:phone-ext]
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:d3a813b7ce44062a0bf05c46ffe9add7
title
Bristol-Myers Squibb
@en
type
label
Bristol-Myers Squibb [clinicaltrials_resource:d3a813b7ce44062a0bf05c46ffe9add7]
@en